Naftopidil for the treatment of benign prostate hyperplasia: a systematic review

Author： Castiglione Fabio   Benigni Fabio   Briganti Alberto   Salonia Andrea   Villa Luca   Nini Alessandro   Di Trapani Ettore   Capitanio Umberto   Hedlund Petter   Montorsi Francesco  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.30, Iss.4, 2014-04, pp. : 719-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2014-12 ,pp. : 249-254

Karger

Access to resources Recommend Favorite

Risk of fractures associated with treatment for benign prostate hyperplasia in men

By Vestergaard P.   Rejnmark L.   Mosekilde L.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 731-737

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of Doxazosin in the Treatment of Acute Urinary Retention due to Benign Prostate Hyperplasia

By  

Urologia Internationalis, Vol. 81, Iss. 1, 2008-07 ,pp. : 66-71

Karger

Access to resources Recommend Favorite

A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily

By  

Urologia Internationalis, Vol. 85, Iss. 1, 2010-06 ,pp. : 80-87

Karger

Access to resources Recommend Favorite

Transurethral Needle Ablation of the Prostate: An Alternative Minimally Invasive Therapeutic Concept in the Treatment of Benign Prostate Hyperplasia

By  

Urologia Internationalis, Vol. 61, Iss. 2, 1999-01 ,pp. : 104-110

Karger

Access to resources Recommend Favorite